A detailed history of Grant transactions in Astrazeneca PLC stock. As of the latest transaction made, Grant holds 3,160 shares of AZN stock, worth $212,352. This represents 0.12% of its overall portfolio holdings.

Number of Shares
3,160
Previous 3,237 2.38%
Holding current value
$212,352
Previous $252,000 2.38%
% of portfolio
0.12%
Previous 0.13%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$76.67 - $87.62 $5,903 - $6,746
-77 Reduced 2.38%
3,160 $246,000
Q2 2024

Jul 22, 2024

BUY
$66.81 - $80.83 $4,676 - $5,658
70 Added 2.21%
3,237 $252,000
Q1 2024

Apr 25, 2024

BUY
$61.03 - $69.57 $427 - $486
7 Added 0.22%
3,167 $214,000
Q3 2023

Oct 24, 2023

BUY
$64.85 - $71.7 $194 - $215
3 Added 0.1%
3,160 $213,000
Q2 2023

Jul 19, 2023

BUY
$69.91 - $75.81 $220,705 - $239,332
3,157 New
3,157 $225,000
Q4 2022

Jan 10, 2023

BUY
$54.21 - $70.44 $170,761 - $221,886
3,150 New
3,150 $0

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $208B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Grant Portfolio

Follow Grant and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grant, based on Form 13F filings with the SEC.

News

Stay updated on Grant with notifications on news.